Experimental anti-obesity drug may control appetite without surgery or nausea

Imagine getting the benefits of gastric bypass surgery without going under the knife -; a new class of compounds could do just that. In lab animals, these potential treatments reduce weight dramatically and lower blood glucose.

Related Keywords

United States ,American ,Robert Doyle ,Heath Schmidt ,Christian Roth ,Emily Henderson ,Cancer Research ,Seattle Children Research Institute ,Cancer Research Industry ,American Chemical Society ,Syracuse University ,Drug Administration ,University Of Pennsylvania ,Medical University ,Seattle Children ,Research Industry Focus ,Nausea ,Obesity ,Surgery ,Weight Loss ,Bariatric Surgery ,Flood ,Blood Sugar ,Rain ,Turn ,Chemotherapy ,Compound ,Covid 19 ,Diabetes ,Drugs ,Wood ,Gastric Bypass ,Gastric Bypass Surgery ,Glp 1 ,Glucagon ,Glucagon Like Peptide 1 ,Glucose ,Ormone ,Insulin ,Muscle ,Pancreas ,Pandemic ,Mh ,Eceptor ,Research ,Type 2 Diabetes ,Vomiting ,